Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02742116
Other study ID # ECSFPA1.0
Secondary ID
Status Completed
Phase N/A
First received April 13, 2016
Last updated November 1, 2016
Start date July 2016
Est. completion date October 2016

Study information

Verified date November 2016
Source The University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority Hong Kong: Department of Health
Study type Observational

Clinical Trial Summary

The objectives are to:

1. Assess patient's views and preferences in receiving expanded carrier screening

2. Perform qualitative study on post testing counselling on screen positive individuals and at risk couples


Description:

This study is to recruit 50 couples for Expanded carrier screening at Prepregnancy Checkup Clinic at the Family Planning Association.

Saliva swabs are collected from couples for Hereditary Disease DNA screening test by DrGene.

Blood samples are taken by venipuncture of women for Fragile X carrier screening by Prenatal Diagnostic Laboratory, Tsan Yuk Hospital.

A pre-test self-administered Questionnaire 1 will be administered to couples to assess their knowledge, views and preferences in receiving expanded carrier screening. This include collection of basic demographic information, answers to questions on basic principles of expanded carrier testing, reasons of having or declining the test, choice of having concurrent or sequential screening, factors affecting their choices, anxiety level of the patient is assessed by state-trait anxiety inventory. Their willingness to pay for the test is also assessed.

The test results will be available to couples in 6 week's time. A post-test self-administered questionnaire 2 will be administered to couples on receiving the test results at the clinic. These include assessment of anxiety level, any decision regret, outcome of test and resulting action.

The couples with a screen positive result will be referred to Queen Mary Hospital for a joint counselling by clinical geneticist and gynaecologist. This counselling/consultation shall be audiotaped or videotaped. The interviews will be transcribed verbatim. The data will be explored for themes and issues identified.

Statistics Questionnaire survey data shall be entered into SPSS. Descriptive statistics will be used to compare responses and choices of participants.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date October 2016
Est. primary completion date October 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Ethnic Chinese couples who attend prepregnancy clinic

- Age 18 or above

Exclusion Criteria:

- Couples who cannot read or understand Chinese or English

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Genetic:
DNA screening before Pregnancy
Saliva/swab shall be collected from couple for Hereditary Disease DNA screening test. Blood sample shall be taken by venipuncture of women for Fragile X carrier screening A pre-test questionnaire will be conducted to assess subject's knowledge, views and preferences in receiving expanded carrier screening, choice of having concurrent or sequential screening, factors affecting their choices, anxiety level, and their willingness to pay for the test. A post-test self-administered questionnaire shall be filled in by the patient on receiving the test results. Couples who receive a screen positive result shall be subsequently referred to Queen Mary Hospital for joint counselling by clinical geneticist and gynaecologist. This consultation shall be audiotaped or videotaped.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
The University of Hong Kong The Family Planning Association of Hong Kong

Outcome

Type Measure Description Time frame Safety issue
Primary Patient acceptance and literacy of expanded carrier screening Factors affecting the choice of expanded carrier screening in the prepregnancy and subfertility patients Identify counselling issues when expanded carrier screening is offered in the local setting 6 weeks No
Secondary Patient acceptance and literacy of expanded carrier screening cost, false positives, workload generated from offering expanded carrier screening 6 months No
See also
  Status Clinical Trial Phase
Completed NCT03988504 - Impact of Predictive Genetic Testing
Not yet recruiting NCT05159011 - Access to Genetic Information Leveraging Innovative Technology (AGILITY) N/A
Recruiting NCT02691689 - Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions N/A
Completed NCT04704193 - Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes N/A
Completed NCT05545254 - Health-promoting Lifestyle in a Genetic Counseling Clinic
Recruiting NCT05348564 - Comparing Direct vs Indirect Methods for Cascade Screening N/A
Recruiting NCT05360095 - Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education N/A
Active, not recruiting NCT03869515 - Genetic Causes and Clinical Features of Childhood Interstitial Lung Diseases in China
Recruiting NCT04856696 - Clinical Application of Non-invasive PGT-A N/A
Recruiting NCT04481061 - Engaging Adolescents in Decisions About Return of Genomic Research Results N/A
Recruiting NCT04656028 - Genetic Testing and Motivational Counseling for FH N/A
Recruiting NCT03396341 - Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
Active, not recruiting NCT04245176 - Genetic Testing for All Breast Cancer Patients (GET FACTS) N/A
Active, not recruiting NCT02665195 - Prospective Registry of Multiplex Testing (PROMPT)
Recruiting NCT06073626 - Personalized Oncology Promoting Equity for Black Lives N/A
Recruiting NCT05225428 - Video Education With Result Dependent dIsclosure N/A
Active, not recruiting NCT05265624 - The Moran AMD Genetic Testing Assessment Study Phase 2
Withdrawn NCT01663584 - Multi-disease Carrier Screening Test Validation N/A
Recruiting NCT05055700 - Impact of a Mobile App on Pregnant Women's Prenatal Genetic Testing Decision-making N/A